370 related articles for article (PubMed ID: 19497422)
1. Structure-dependent activation of peroxisome proliferator-activated receptor (PPAR) gamma by organotin compounds.
Hiromori Y; Nishikawa J; Yoshida I; Nagase H; Nakanishi T
Chem Biol Interact; 2009 Jul; 180(2):238-44. PubMed ID: 19497422
[TBL] [Abstract][Full Text] [Related]
2. Molecular targets of organotin compounds in endocrine disruption: do organotin compounds function as aromatase inhibitors in mammals?
Nakanishi T; Nishikawa J; Tanaka K
Environ Sci; 2006; 13(2):89-100. PubMed ID: 16788560
[TBL] [Abstract][Full Text] [Related]
3. Organotin compounds cause structure-dependent induction of progesterone in human choriocarcinoma Jar cells.
Hiromori Y; Yui H; Nishikawa J; Nagase H; Nakanishi T
J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt B):190-8. PubMed ID: 25465476
[TBL] [Abstract][Full Text] [Related]
4. Organotin mixtures reveal interactions that modulate adipogenic differentiation in 3T3-L1 preadipocytes.
Ticiani E; Pu Y; White M; Adomshick V; Veiga-Lopez A
Arch Toxicol; 2023 Jun; 97(6):1649-1658. PubMed ID: 37142754
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for PPARγ transactivation by endocrine-disrupting organotin compounds.
Harada S; Hiromori Y; Nakamura S; Kawahara K; Fukakusa S; Maruno T; Noda M; Uchiyama S; Fukui K; Nishikawa J; Nagase H; Kobayashi Y; Yoshida T; Ohkubo T; Nakanishi T
Sci Rep; 2015 Feb; 5():8520. PubMed ID: 25687586
[TBL] [Abstract][Full Text] [Related]
6. Organotin compounds promote adipocyte differentiation as agonists of the peroxisome proliferator-activated receptor gamma/retinoid X receptor pathway.
Kanayama T; Kobayashi N; Mamiya S; Nakanishi T; Nishikawa J
Mol Pharmacol; 2005 Mar; 67(3):766-74. PubMed ID: 15611480
[TBL] [Abstract][Full Text] [Related]
7. Tributyltin and triphenyltin exposure promotes in vitro adipogenic differentiation but alters the adipocyte phenotype in rainbow trout.
Lutfi E; Riera-Heredia N; Córdoba M; Porte C; Gutiérrez J; Capilla E; Navarro I
Aquat Toxicol; 2017 Jul; 188():148-158. PubMed ID: 28527383
[TBL] [Abstract][Full Text] [Related]
8. Organotin compounds enhance 17beta-hydroxysteroid dehydrogenase type I activity in human choriocarcinoma JAr cells: potential promotion of 17beta-estradiol biosynthesis in human placenta.
Nakanishi T; Hiromori Y; Yokoyama H; Koyanagi M; Itoh N; Nishikawa J; Tanaka K
Biochem Pharmacol; 2006 Apr; 71(9):1349-57. PubMed ID: 16513093
[TBL] [Abstract][Full Text] [Related]
9. Some organotin compounds enhance histone acetyltransferase activity.
Osada S; Nishikawa J; Nakanishi T; Tanaka K; Nishihara T
Toxicol Lett; 2005 Feb; 155(2):329-35. PubMed ID: 15603928
[TBL] [Abstract][Full Text] [Related]
10. Organotins are potent activators of PPARγ and adipocyte differentiation in bone marrow multipotent mesenchymal stromal cells.
Yanik SC; Baker AH; Mann KK; Schlezinger JJ
Toxicol Sci; 2011 Aug; 122(2):476-88. PubMed ID: 21622945
[TBL] [Abstract][Full Text] [Related]
11. Rhodanine derivatives as novel peroxisome proliferator-activated receptor gamma agonists.
Liu Q; Zhang YY; Lu HL; Li QY; Zhou CH; Wang MW
Acta Pharmacol Sin; 2007 Dec; 28(12):2033-9. PubMed ID: 18031620
[TBL] [Abstract][Full Text] [Related]
12. Butyl and phenyl tin compounds in fish and shellfish on the Korean market.
Oh CH
Bull Environ Contam Toxicol; 2009 Aug; 83(2):239-43. PubMed ID: 19424649
[TBL] [Abstract][Full Text] [Related]
13. Assessment of butyl- and phenyltin pollution in the coastal environment of Korea using mussels and oysters.
Shim WJ; Hong SH; Kim NS; Yim UH; Li D; Oh JR
Mar Pollut Bull; 2005; 51(8-12):922-31. PubMed ID: 16125738
[TBL] [Abstract][Full Text] [Related]
14. Developmental effects: oestrogen-induced vaginal changes and organotin-induced adipogenesis.
Iguchi T; Watanabe H; Ohta Y; Blumberg B
Int J Androl; 2008 Apr; 31(2):263-8. PubMed ID: 18248399
[TBL] [Abstract][Full Text] [Related]
15. Endocrine disruption induced by organotin compounds; organotins function as a powerful agonist for nuclear receptors rather than an aromatase inhibitor.
Nakanishi T
J Toxicol Sci; 2008 Aug; 33(3):269-76. PubMed ID: 18670157
[TBL] [Abstract][Full Text] [Related]
16. Tri-substituted organotin compounds, but not retinoic acid, are potent ligands of complement component 8 γ.
Yamamoto K; Hiromori Y; Matsumaru D; Ishii Y; Takeshita Y; Tsubakihara I; Kimura T; Nagase H; Nakanishi T
J Toxicol Sci; 2020; 45(9):581-587. PubMed ID: 32879257
[TBL] [Abstract][Full Text] [Related]
17. Transactivation of the human retinoid X receptor by organotins: use of site-directed mutagenesis to identify critical amino acid residues for organotin-induced transactivation.
Hiromori Y; Aoki A; Nishikawa J; Nagase H; Nakanishi T
Metallomics; 2015 Jul; 7(7):1180-8. PubMed ID: 25985376
[TBL] [Abstract][Full Text] [Related]
18. A rapid, homogeneous, fluorescence polarization binding assay for peroxisome proliferator-activated receptors alpha and gamma using a fluorescein-tagged dual PPARalpha/gamma activator.
Seethala R; Golla R; Ma Z; Zhang H; O'Malley K; Lippy J; Cheng L; Mookhtiar K; Farrelly D; Zhang L; Hariharan N; Cheng PT
Anal Biochem; 2007 Apr; 363(2):263-74. PubMed ID: 17335769
[TBL] [Abstract][Full Text] [Related]
19. PAR-1622 is a selective peroxisome proliferator-activated receptor gamma partial activator with preserved antidiabetic efficacy and broader safety profile for fluid retention.
Kim MK; Chae YN; Kim HS; Choi SH; Son MH; Kim SH; Kim JK; Moon HS; Park SK; Shin YA; Kim JG; Lee CH; Lim JI; Shin CY
Arch Pharm Res; 2009 May; 32(5):721-7. PubMed ID: 19471887
[TBL] [Abstract][Full Text] [Related]
20. Ligand Activity of Group 15 Compounds Possessing Triphenyl Substituent for the RXR and PPARγ Nuclear Receptors.
Hiromori Y; Ido A; Aoki A; Kimura T; Nagase H; Nakanishi T
Biol Pharm Bull; 2016; 39(10):1596-1603. PubMed ID: 27725436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
